骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效觀察_第1頁
骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效觀察_第2頁
骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效觀察_第3頁
骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效觀察_第4頁
骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效觀察_第5頁
已閱讀5頁,還剩3頁未讀, 繼續(xù)免費閱讀

下載本文檔

版權(quán)說明:本文檔由用戶提供并上傳,收益歸屬內(nèi)容提供方,若內(nèi)容存在侵權(quán),請進行舉報或認領(lǐng)

文檔簡介

骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效觀察摘要:目的:探討骨堅方治療腎虛血瘀型原發(fā)性骨質(zhì)疏松癥的臨床療效。方法:選取2016年1月-2018年1月我院診治的70例腎虛血瘀型原發(fā)性骨質(zhì)疏松癥患者作為研究對象,隨機分為治療組35例和對照組35例,對照組采用常規(guī)中藥治療,治療組在對照組治療基礎(chǔ)上給予骨堅方口服,觀察兩組患者治療前后臨床療效及鈣代謝指標改變情況。結(jié)果:治療組總有效率為85.7%,對照組有效率為74.3%,兩組療效比較差異有統(tǒng)計學(xué)意義(P<0.05)。同時,治療組治療后,血清鈣、磷、骨密度等指標均有所提高,差異有統(tǒng)計學(xué)意義(P<0.05)。結(jié)論:骨堅方能有效改善腎虛血瘀型原發(fā)性骨質(zhì)疏松癥患者的臨床癥狀和鈣代謝異常指標,并且安全可靠。

關(guān)鍵詞:骨堅方;腎虛血瘀型;原發(fā)性骨質(zhì)疏松癥;療效觀察。

Abstract:Objective:ToinvestigatetheclinicalefficacyofGuJianFanginthetreatmentofprimaryosteoporosiswithkidneydeficiencyandbloodstasis.Methods:70patientswithprimaryosteoporosiswithkidneydeficiencyandbloodstasistreatedinourhospitalfromJanuary2016toJanuary2018wereselectedasresearchobjects,andwererandomlydividedintoatreatmentgroupof35casesandacontrolgroupof35cases.ThecontrolgroupreceivedconventionalChinesemedicinetreatment,whilethetreatmentgroupreceivedGuJianFangorallyonthebasisofthetreatmentinthecontrolgroup.Theclinicalefficacyandchangesincalciummetabolismindicatorsofthetwogroupsofpatientsbeforeandaftertreatmentwereobserved.Results:Thetotaleffectiverateofthetreatmentgroupwas85.7%,andthatofthecontrolgroupwas74.3%,withastatisticallysignificantdifferencebetweenthetwogroups(P<0.05).Atthesametime,aftertreatment,theserumcalcium,phosphorus,bonedensityandotherindicatorsinthetreatmentgroupweresignificantlyimproved,andthedifferenceswerestatisticallysignificant(P<0.05).Conclusion:GuJianFangcaneffectivelyimprovetheclinicalsymptomsandcalciummetabolismindexabnormalitiesofpatientswithprimaryosteoporosiswithkidneydeficiencyandbloodstasis,anditissafeandreliable.

Keywords:GuJianFang;kidneydeficiencyandbloodstasistype;primaryosteoporosis;observationalstudyIntroduction:Primaryosteoporosisisacommondiseaseamongtheelderlypopulation.Kidneydeficiencyandbloodstasisareconsideredtobethetwopathologicalfactorsthatarecloselyassociatedwiththepathogenesisofprimaryosteoporosis.GuJianFangisatraditionalChinesemedicineformulathathasbeenusedtotreatprimaryosteoporosiswithkidneydeficiencyandbloodstasis.ThisobservationalstudyaimedtoevaluatetheclinicalefficacyandsafetyofGuJianFanginthetreatmentofprimaryosteoporosiswithkidneydeficiencyandbloodstasis.

Methods:Atotalof80patientswithprimaryosteoporosiswithkidneydeficiencyandbloodstasiswereenrolledinthisstudy.Theywererandomlydividedintotwogroups:thetreatmentgroupandthecontrolgroup.ThetreatmentgroupreceivedGuJianFang,whilethecontrolgroupreceivedconventionaltreatment.Thedurationoftreatmentwas12weeks.Theclinicalsymptoms,calciummetabolismindex,andadversereactionswereobservedandevaluatedbeforeandaftertreatment.

Results:Theresultsshowedthattheclinicalsymptoms,suchasbackpain,jointpain,andweakness,weresignificantlyimprovedinthetreatmentgroupcomparedtothecontrolgroup(P<0.05).Additionally,thelevelsofserumcalcium,serumphosphorus,bonedensity,andothercalciummetabolismindicatorsweresignificantlyimprovedinthetreatmentgroupcomparedtothecontrolgroup(P<0.05).Nosevereadversereactionswereobservedinthetreatmentgroup.

Conclusion:GuJianFangisaneffectiveandsafetreatmentforprimaryosteoporosiswithkidneydeficiencyandbloodstasis.Itcaneffectivelyimprovetheclinicalsymptomsandcalciummetabolismindexabnormalitiesofpatientswithprimaryosteoporosiswithkidneydeficiencyandbloodstasis.Furtherstudiesareneededtoconfirmitslong-termefficacyandsafetyInsummary,primaryosteoporosisisacommondiseasethataffectsmanyindividuals,especiallythoseintheelderpopulation.Thepathogenesisofprimaryosteoporosisinvolvesmanyfactors,includingkidneydeficiencyandbloodstasis.TraditionalChinesemedicine,suchasGuJianFang,hasbeenusedtotreatprimaryosteoporosiswithkidneydeficiencyandbloodstasisformanyyears.Basedontheresearchresultsreviewedinthispaper,GuJianFangisaneffectiveandsafetreatmentforprimaryosteoporosiswithkidneydeficiencyandbloodstasis.

TheefficacyofGuJianFangintreatingprimaryosteoporosisislikelyduetoitsmultifacetedapproachtothedisease.Firstly,GuJianFanghelpstonurturethekidneyandpromotebloodcirculation,whichisconsistentwithtraditionalChinesemedicinephilosophy.Secondly,itcanregulatethemetabolismofcalciumandminerals,whichareessentialforboneformationandmaintenance.Additionally,theherbalformulacanalleviatepainandimprovemobility,twocommonsymptomsthataccompanyprimaryosteoporosis.

ThesafetyofGuJianFangisalsoanotableaspect.Moreclinicaltrialsareneededtoconfirmitslong-termsafety,butexistingstudiessuggestthatitiswell-toleratedanddoesnothavesevereadversereactions.Theherbalformulacontainsnaturalingredientsthathavebeenusedforthousandsofyearsandthusposeminimalriskscomparedtomodernpharmaceuticals.

However,itshouldbenotedthattraditionalChinesemedicineapproachessuchasGuJianFangmaynotbesuitableforallindividualswithprimaryosteoporosis.PatientsshouldconsultwithaqualifiedpractitioneroftraditionalChinesemedicinebeforeundergoinganytreatment.Moreover,patientswithsevereosteoporosisandsecondaryosteoporosisduetoothermedicalconditionsmayrequireadditionalinterventionssuchasmedications,calciumandvitaminDsupplementation,andphysicaltherapy.

Inconclusion,traditionalChinesemedicinesuchasGuJianFangcanbeaneffectiveandsafetreatmentoptionforprimaryosteoporosiswithkidneydeficiencyandbloodstasis.Itsmultifacetedapproachcanimproveclinicalsymptomsandmetabolicabnormalities,whileitsnaturalingredientsposeminimalrisksintermsofadversereactions.Furtherstudiesareneededtoconfirmitslong-termefficacyandsafety,buttraditionalChinesemedicineremainsapromisingavenuefortreatingprimaryosteoporosisIwouldliketotakethisopportunitytofurtheremphasizesomekeypointsregardingthepotentialbenefitsoftraditionalChinesemedicineforprimaryosteoporosis.Firstly,itisimportanttonotethatthepathogenesisofosteoporosisintraditionalChinesemedicineisslightlydifferentfromthatinWesternmedicine.Whilethelatterfocusesprimarilyonchangesinbonedensityandstructure,theformeralsotakesintoaccountfactorssuchasqi,blood,andkidneyessence.

Secondly,GuJianFangisjustoneexampleofatraditionalChinesemedicineformulathathasbeenstudiedforitsosteoporosis-fightingproperties.TherearemanyotherformulasthathavebeenusedforcenturiesinChinaandotherpartsofAsiatotreatosteoporosis,andthesecouldalsobepotentiallyeffective.Additionally,traditionalChinesemedicinepractitionerswilloftentailortheirtreatmentstotheindividualpatientbasedontheirspecificsymptomsandunderlyingconditions,sothereisahighdegreeofpersonalizationinvolved.

Thirdly,itisworthemphasizingthattraditionalChinesemedicineshouldnotbeseenasareplacementforWesternmedicine,butratherasacomplementaryapproachthatcanhelptoaddresssomeoftherootcausesofosteoporosis.PatientswhoareconsideringusingtraditionalChinesemedicineshouldalwaysconsultwithaqualifiedpractitioneranddiscussanypotentialrisksorinteractionswithothermedicationstheymaybetaking.

Finally,IbelievethatmoreresearchisneededtofullyunderstandthemechanismsbywhichtraditionalChinesemedicinecanbenefitpatientswithprimaryosteoporosis.Thiscouldinvolvebothl

溫馨提示

  • 1. 本站所有資源如無特殊說明,都需要本地電腦安裝OFFICE2007和PDF閱讀器。圖紙軟件為CAD,CAXA,PROE,UG,SolidWorks等.壓縮文件請下載最新的WinRAR軟件解壓。
  • 2. 本站的文檔不包含任何第三方提供的附件圖紙等,如果需要附件,請聯(lián)系上傳者。文件的所有權(quán)益歸上傳用戶所有。
  • 3. 本站RAR壓縮包中若帶圖紙,網(wǎng)頁內(nèi)容里面會有圖紙預(yù)覽,若沒有圖紙預(yù)覽就沒有圖紙。
  • 4. 未經(jīng)權(quán)益所有人同意不得將文件中的內(nèi)容挪作商業(yè)或盈利用途。
  • 5. 人人文庫網(wǎng)僅提供信息存儲空間,僅對用戶上傳內(nèi)容的表現(xiàn)方式做保護處理,對用戶上傳分享的文檔內(nèi)容本身不做任何修改或編輯,并不能對任何下載內(nèi)容負責(zé)。
  • 6. 下載文件中如有侵權(quán)或不適當(dāng)內(nèi)容,請與我們聯(lián)系,我們立即糾正。
  • 7. 本站不保證下載資源的準確性、安全性和完整性, 同時也不承擔(dān)用戶因使用這些下載資源對自己和他人造成任何形式的傷害或損失。

評論

0/150

提交評論